Leptin Increases Cardiomyocyte Hyperplasia via Extracellular Signal-Regulated Kinase- and Phosphatidylinositol 3-Kinase-Dependent Signaling Pathways
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Obesity is a major risk factor for the development of heart failure. Importantly, it is now appreciated that a change in the number of myocytes is one of multiple structural and functional alterations (remodeling) leading to heart failure. Here we investigate the effect of leptin, the product of the obese (ob) gene, on proliferation of human and murine cardiomyocytes. Leptin caused a time- and dose-dependent significant increase in proliferation of HL-1 cells that was inhibited by preincubation with PD98059 and LY294002, suggesting that leptin mediated proliferation via extracellular signal-regulated kinase-1/2- and phosphatidylinositol-3-kinase-dependent signaling pathways. We confirmed that leptin activates both extracellular signal-regulated kinase-1/2 phosphorylation and association of phosphatidylinositol-3-kinase (regulatory p85 subunit) with phosphotyrosine immunoprecipitates. We also examined bromodeoxyuridine incorporation as a measure of new DNA synthesis and demonstrated a stimulatory effect of leptin in both HL-1 cells and human cardiomyocytes. Bromodeoxyuridine incorporation in HL-1 cells was inhibited by PD98059 and LY294002. Our results establish a mitogenic effect of leptin in cardiomyocytes and provide additional evidence for a potential direct link between leptin and cardiac remodeling in obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1155 · Cited by 3,725
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Claycomb, W. C., Lanson, N. A., Stallworth, B. S., Egeland, D. B., Delcarpio, J. B., Bahinski, A., & Izzo, N. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2979 · Cited by 1,546 · cited 4×
“To investigate the effect of leptin on cardiomyocyte hyperplasia we have used both isolated pediatric human cardiomyocytes and an established murine cardiomyocyte cell line (17, 19).”
BackgroundMethodInfluentialAhima, R. S., & Flier, J. S. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.413 · Cited by 1,428
Barouch, L. A., Berkowitz, D. E., Harrison, R. W., O’Donnell, C. P., & Hare, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000083716.82622.fd · Cited by 341 · cited 2×
“Intriguingly, a direct impact of leptin on remodeling was recently demonstrated by correction of ventricular hypertrophy in ob/ob mice upon injection of leptin (16).”
BackgroundLicinio, J., Negrão, A. B., Mantzoros, C., Kaklamani, V., Wong, M.-L., Bongiorno, P. B., Mulla, A., Cearnal, L., Veldhuis, J. D., Flier, J. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2541 · Cited by 287
Sweeney, G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(02)00006-2 · Cited by 271
Self-citationThe Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes
Rajapurohitam, V., Gan, X. T., Kirshenbaum, L. A., & Karmazyn, M. (2003) · Circulation Research · doi:10.1161/01.res.0000089255.37804.72 · Cited by 248
Obesity in the United States: A Fresh Look at Its High Toll
Manson, J. E., & Bassuk, S. S. (2003) · JAMA · doi:10.1001/jama.289.2.229 · Cited by 161 · cited 1×
“T EMERGING OBESITY epidemic (1) is recognized as an independent risk factor for congestive heart failure,”
Background
Cited by
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
Leptin Signaling and Obesity: Cardiovascular Consequences
Yang, R., & Barouch, L. A. (2007) · Circulation Research · doi:10.1161/circresaha.107.156596 · Cited by 331
Role of adipokines in cardiovascular disease
Mattu, H. S., & Randeva, H. S. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0232 · Cited by 292
Rat heart is a site of leptin production and action
Purdham, D. M., Zou, M.-X., Rajapurohitam, V., & Karmazyn, M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00499.2004 · Cited by 173
“In this regard, we recently demonstrated a direct hypertrophic effect of the peptide on cultured neonatal rat ventricular myocytes acting via the p38 MAPK system (20), whereas others have shown that leptin can stimulate proliferation of cardiac-derived HL-1 cells (22).”
BackgroundLeptin, the obesity‐associated hormone, exhibits direct cardioprotective effects
Smith, C. C. T., Mocanu, M. M., Davidson, S. M., Wynne, A. M., Simpkin, J. C., & Yellon, D. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706834 · Cited by 153
“Indeed, the heart expresses leptin receptors and, interestingly, synthesises leptin itself, releasing it into the coronary effluent, raising the possibility that leptin of cardiac origin feeds back onto the cardiomyocyte to exert physiological effects (Winnicki et al., 2001; Purdham et al., 2004).”
BackgroundSáinz, N., Rodríguez, A., Catalán, V., Becerril, S., Ramírez, B., Gómez-Ambrosi, J., & Frühbeck, G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006808 · Cited by 135
“These findings are in accordance with the mitogenic effects described for leptin in vascular endothelial cells [55], hepatocytes [56] cardiomyocytes [57], vascular smooth muscle cells [58], and myoblasts [59].”
ResultMADANI, S., DEGIROLAMO, S., MUNOZ, D., LI, R., & SWEENEY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.11.022 · Cited by 122
“The final choice of inhibitor concentrations used here was determined by preliminary experiments and our previous work in these cells [24].”
MethodSelf-citationRajapurohitam, V., Javadov, S., Purdham, D. M., Kirshenbaum, L. A., & Karmazyn, M. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.05.001 · Cited by 102
“A particularly potentially interesting role for leptin is the development of cardiac hypertrophy based on a number of recent observations which have demonstrated that leptin can induce cardiomyocyte hypertrophy (or increased proliferation of cultured HL-1 cells) through mechanisms possibly involving MAPK activation [8…”
BackgroundAbe, Y., Ono, K., Kawamura, T., Wada, H., Kita, T., Shimatsu, A., & Hasegawa, K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00579.2006 · Cited by 97
“Several recent studies have supplied evidence that leptin directly induces hypertrophy in cardiomyocytes in culture (13, 20, 26, 29).”
BackgroundElectrophysiological Characterization of Left Ventricular Myocytes from Obese Sprague‐Dawley Rat
Ricci, E., Smallwood, S., Chouabe, C., Mertani, H. C., Raccurt, M., Morel, G., & Bonvallet, R. (2006) · Obesity · doi:10.1038/oby.2006.90 · Cited by 33
Metadata
- Authors
- Tajmir, P., Ceddia, R. B., Li, R.-K., Coe, I. R., & Sweeney, G.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2004-04-01
- Volume
- 145
- Issue
- 4
- Pages
- 1550-1555
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2115719865
- Cited by
- 98
- References
- 10
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.